Literature DB >> 16166622

Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia.

Ozden Altiok1, Ryuji Yasumatsu, Gulbin Bingol-Karakoc, Richard J Riese, Mildred T Stahlman, William Dwyer, Richard A Pierce, Dieter Bromme, Ekkehard Weber, Sule Cataltepe.   

Abstract

RATIONALE: Bronchopulmonary dysplasia (BPD) continues to be a major morbidity in preterm infants. The lung pathology in BPD is characterized by impaired alveolar and capillary development. An imbalance between proteases and protease inhibitors in association with changes in lung elastic fibers has been implicated in the pathogenesis of BPD.
OBJECTIVE: To investigate the expression and activity levels of papain-like lysosomal cysteine proteases, cathepsins B, H, K, L, S, and their inhibitors, cystatins B and C, in a baboon model of BPD.
METHODS: Real-time reverse transcriptase-polymerase chain reaction, immunohistochemistry, immunoblotting, active site labeling of cysteine proteases, and in situ hybridization were performed.
MEASUREMENTS AND MAIN RESULTS: The steady-state mRNA and protein levels of all cathepsins were significantly increased in the lung tissue of baboons with BPD. In contrast, the steady-state mRNA and protein levels of two major cysteine protease inhibitors, cystatin B and C, were unchanged. Correlating with these alterations, the activity of cysteine proteases in lung tissue homogenates and bronchoalveolar lavage fluid was significantly higher in the BPD group. The levels of cathepsin B, H, and S increased and cathepsin K decreased with advancing gestation. All cathepsins, except for cat K, were immunolocalized to macrophages in BPD. In addition, cathepsin H and cystatin B were colocalized in type 2 alveolar epithelial cells. Cathepsin L was detected in some bronchial epithelial, endothelial, and interstitial cells. Cathepsin K was localized to some perivascular cells by in situ hybridization.
CONCLUSIONS: Cumulatively, these findings demonstrate an imbalance between cysteine proteases and their inhibitors in BPD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166622      PMCID: PMC2662933          DOI: 10.1164/rccm.200503-425OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  54 in total

1.  Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

Authors:  W S Hou; D Brömme; Y Zhao; E Mehler; C Dushey; H Weinstein; C S Miranda; C Fraga; F Greig; J Carey; D L Rimoin; R J Desnick; B D Gelb
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  Expression of cathepsin K in lung epithelial cells.

Authors:  F Bühling; A Gerber; C Häckel; S Krüger; T Köhnlein; D Brömme; D Reinhold; S Ansorge; T Welte
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

3.  Effect of preterm birth on pulmonary function at school age: a prospective controlled study.

Authors:  S J Gross; D M Iannuzzi; D A Kveselis; R D Anbar
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

4.  Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease.

Authors:  Donald C McCurnin; Richard A Pierce; Ling Yi Chang; Linda L Gibson; Sherri Osborne-Lawrence; Bradley A Yoder; Jay D Kerecman; Kurt H Albertine; Vicki T Winter; Jacqueline J Coalson; James D Crapo; Peter H Grubb; Philip W Shaul
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-12-10       Impact factor: 5.464

5.  Neonatal chronic lung disease in extremely immature baboons.

Authors:  J J Coalson; V T Winter; T Siler-Khodr; B A Yoder
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

6.  Fibroblast tropoelastin and alpha-smooth-muscle actin expression are repressed by particulate-activated macrophage-derived tumor necrosis factor-alpha in experimental silicosis.

Authors:  T J Mariani; M C Arikan; R A Pierce
Journal:  Am J Respir Cell Mol Biol       Date:  1999-08       Impact factor: 6.914

7.  Chronic lung injury in preterm lambs. Disordered respiratory tract development.

Authors:  K H Albertine; G P Jones; B C Starcher; J F Bohnsack; P L Davis; S C Cho; D P Carlton; R D Bland
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

8.  Impaired distal airway development in mice lacking elastin.

Authors:  D P Wendel; D G Taylor; K H Albertine; M T Keating; D Y Li
Journal:  Am J Respir Cell Mol Biol       Date:  2000-09       Impact factor: 6.914

9.  Impact of a physiologic definition on bronchopulmonary dysplasia rates.

Authors:  Michele C Walsh; Qing Yao; Patricia Gettner; Ellen Hale; Monica Collins; Angelita Hensman; Ruth Everette; Nancy Peters; Nancy Miller; Gerry Muran; Kathy Auten; Nancy Newman; Gina Rowan; Cathy Grisby; Kathy Arnell; Lucy Miller; Bethany Ball; Georgia McDavid
Journal:  Pediatrics       Date:  2004-11       Impact factor: 7.124

10.  Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.

Authors:  A Punturieri; S Filippov; E Allen; I Caras; R Murray; V Reddy; S J Weiss
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

View more
  28 in total

1.  Impact of host proteases on reovirus infection in the respiratory tract.

Authors:  Rachel M Nygaard; Joseph W Golden; Leslie A Schiff
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia.

Authors:  Elisa Ghelfi; Cagatay Karaaslan; Sara Berkelhamer; Serra Akar; Harry Kozakewich; Sule Cataltepe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-22       Impact factor: 6.914

Review 3.  Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review.

Authors:  Zhi-Qun Zhang; Xian-Mei Huang; Hui Lu
Journal:  Eur J Pediatr       Date:  2013-09-01       Impact factor: 3.183

Review 4.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

5.  Serum cystatin C and emphysema: results from the National Health and Nutrition Examination Survey (NHANES).

Authors:  Haala K Rokadia; Shikhar Agarwal
Journal:  Lung       Date:  2012-06       Impact factor: 2.584

6.  Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury.

Authors:  Hiroshi Hirakawa; Richard A Pierce; Gulbin Bingol-Karakoc; Cagatay Karaaslan; Meiqian Weng; Guo-Ping Shi; Ali Saad; Ekkehard Weber; Thomas J Mariani; Barry Starcher; Steve D Shapiro; Sule Cataltepe
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

Review 7.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

8.  Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice.

Authors:  Anne Hilgendorff; Kakoli Parai; Robert Ertsey; Noopur Jain; Edwin F Navarro; Joanna L Peterson; Rasa Tamosiuniene; Mark R Nicolls; Barry C Starcher; Marlene Rabinovitch; Richard D Bland
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

9.  Elastase inhibitory activity of airway α1-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia.

Authors:  Cagatay Karaaslan; Hiroshi Hirakawa; Ryuji Yasumatsu; Ling-Yi L Chang; Richard A Pierce; James D Crapo; Sule Cataltepe
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

10.  Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.

Authors:  Harun Elmasri; Cagatay Karaaslan; Yaroslav Teper; Elisa Ghelfi; Meiqian Weng; Tan A Ince; Harry Kozakewich; Joyce Bischoff; Sule Cataltepe
Journal:  FASEB J       Date:  2009-07-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.